FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
On April 22, 2024, the Food and Drug Administration approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with Bacillus Calmette-Gu érin (BCG) for adult patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papilla (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 22, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Immunotherapy for Renal-Cell Carcinoma Saves Lives Immunotherapy for Renal-Cell Carcinoma Saves Lives
A 5-year randomised, placebo-controlled trial of pembrolizumab found a 38% reduction in death vs placebo.Medscape News UK (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 22, 2024 Category: Consumer Health News Tags: Hematology-Oncology Clinical Summary Source Type: news
My 'sinus infection' turned out to be a one in a million nasal cancer at just 28 - and doctors had to cut my eye out to save me
Annika, 28, from California, was diagnosed with the extremely rare nasal cancer sinonasal carcinoma SMARCB1 after doctors mistook it for a sinus infection. Her cancer is stage four. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2024 Category: Consumer Health News Source Type: news
Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
THURSDAY, April 18, 2024 -- For patients with clear-cell renal cell carcinoma, adjuvant pembrolizumab is associated with a significant and clinically meaningful improvement in overall survival, according to a study published in the April 18 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 18, 2024 Category: Pharmaceuticals Source Type: news
Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors
Reports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Dermatology Clinical Summary Source Type: news
Microwave Ablation Feasible for T1N0M0 Papillary Thyroid Carcinoma
FRIDAY, April 12, 2024 -- For patients with multifocal papillary thyroid carcinoma (PTC), the rates of progression-free survival (PFS) do not differ between microwave ablation (MWA) and surgical resection (SR), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
Immunotherapy After Definitive Therapy Flops in Head and Neck Cancer
(MedPage Today) -- SAN DIEGO -- Patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) who received atezolizumab (Tecentriq) after undergoing multimodal definitive therapy failed to achieve a statistically meaningful... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 10, 2024 Category: Hematology Source Type: news
AACR: Novel Personalized Vaccine Feasible for Head and Neck Cancer
TUESDAY, April 9, 2024 -- The novel viral-based personalized cancer vaccine, TG4050, which encodes up to 30 patient- and tumor-specific sequences is feasible and safe for patients with resected head and neck squamous cell carcinoma, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 9, 2024 Category: Pharmaceuticals Source Type: news
Why Is Moderna Stock Trading Higher Today?
Moderna Inc MRNA stock surged on Tuesday after the company shared the AACR 2024 annual meeting poster presentation of mRNA-4157 (V940) individualized neoantigen therapy plus Merck & Co Inc’s MRK Keytruda (pembrolizumab) in advanced unresectable HPV-negative head and neck carcinoma. In a Phase 1…#modernainc #mrna4157 #v940 #merckcoincs #hpv #ifn #decreases #merck #keytruda (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2024 Category: Consumer Health News Source Type: news
Diagnose Left Flank Pain in a 61-Year-Old Man Diagnose Left Flank Pain in a 61-Year-Old Man
Are you familiar with the presentation, differential diagnosis, and workup for renal cell carcinoma? Dr Karl J. D ' Silva provides a brief guide.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 2, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma?
(MedPage Today) -- The use of microwave ablation to treat ultrasound-detected, multifocal papillary thyroid carcinoma (PTC) was associated with the same outcomes but fewer complications compared with surgical resection, according to results from... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - April 2, 2024 Category: Radiology Source Type: news
Microwave ablation on par with surgery for thyroid cancer survival
Microwave ablation may be a suitable alternative to surgical resection when it comes to ultrasound-detected thyroid cancer, a study published April 2 in Radiology found.
Researchers led by Zhen-Long Zhao, MD, from China-Japan Friendship Hospital in Beijing found no significant difference in progression-free survival rates between patients receiving ablation or surgery. Additionally, microwave ablation led to less blood loss, shorter incision length, and shorter procedure and hospitalization durations.
“Microwave ablation is a feasible option for selected patients with multifocal T1N0M0 papillary thyroid carcinoma,” Z...
Source: AuntMinnie.com Headlines - April 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Philadelphia Teacher Sues District Over Asbestos-Related Cancer
Juan Namnun, an award-winning health and physical education teacher at Frankford High School in Philadelphia, was diagnosed with papillary carcinoma in 2022. His diagnosis led him to file a lawsuit against The School District of Philadelphia.
Papillary carcinoma is a rare type of breast cancer. Following his diagnosis, Namnum underwent a double mastectomy, reconstructive surgery and chemotherapy.
Namnum’s lawsuit claims his diagnosis is “a direct and proximate result of [his] repeated exposure to and inhalation of excessive amounts of asbestos fibers and dust at Frankford High school over a period of mu...
Source: Asbestos and Mesothelioma News - April 1, 2024 Category: Environmental Health Authors: Travis Rodgers Tags: Asbestos (general) Asbestos Exposure Cancer (Non-Meso) Source Type: news
Developing and validating a nomogram to predict suicide risk of patients with head and neck squamous cell carcinoma - Deng J, Ai P.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - April 1, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Studying Cancer Through Simultaneous Genetic and Epigenetic Analysis
Profiling genetic variants and DNA methylation changes in cell free DNA could transform the detection of cancers including hepatocellular carcinoma. (Source: The Scientist)
Source: The Scientist - March 28, 2024 Category: Science Tags: The Marketplace Source Type: news
